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Abstract
Background: Embryo retention in the Fallopian tube (FT) is thought to lead to ectopic pregnancy (EP), a considerable cause
of morbidity. In mice, genetic/pharmacological silencing of cannabinoid receptor Cnr1, encoding CB1, causes retention of
embryos in the oviduct. The role of the endocannabinoids in tubal implantation in humans is not known.
Methods and Findings: Timed FT biopsies (n=18) were collected from women undergoing gynecological procedures for
benign conditions. Endometrial biopsies and whole blood were collected from women undergoing surgery for EP (n=11);
management of miscarriage (n=6), and termination of pregnancy (n=8). Using RT-PCR and immunohistochemistry, CB1
mRNA and protein expression levels/patterns were examined in FT and endometrial biopsies. The distribution of two
polymorphisms of CNR1 was examined by TaqMan analysis of genomic DNA from the whole blood samples. In normal FT, CB1
mRNA washigherinlutealcompared tofollicular-phase(p,0.05).CB1protein waslocated insmoothmuscleof the wall andof
endothelial vessels, and luminal epithelium of FT. In FT from women with EP, CB1 mRNA expression was low. CB1 mRNA
expression was also significantly lower (p,0.05) in endometrium of women with EP compared to intrauterine pregnancies
(IUP). Although of 1359G/A (rs1049353) polymorphisms of CNR1 gene suggests differential distribution of genotypes between
the small, available cohorts of women with EP and those with IUP, results were not statistically significant.
Conclusions: CB1 mRNA shows temporal variation in expression in human FT, likely regulated by progesterone. CB1 mRNA
is expressed in low levels in both the FT and endometrium of women with EP. We propose that aberrant endocannabinoid-
signaling in human FT leads to EP. Furthermore, our finding of reduced mRNA expression along with a possible association
between polymorphism genotypes of the CNR1 gene and EP, suggests a possible genetic predisposition to EP that warrants
replication in a larger sample pool.
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Introduction
Tubal ectopic pregnancy remains a common cause of morbidity
and occasional mortality [1]. In the UK, between 2003 and 2005,
early pregnancy bleeding was the third commonest cause of
maternal death and over 60% of these cases were due to ruptured
tubal ectopic pregnancies [2]. In the USA, ruptured tubal ectopic
pregnancy remains the commonest cause of pregnancy-related first
trimester death [3]. Unfortunately, our knowledge of the complex
molecular and cellular interactions that contribute to tubal
implantation is limited. Nevertheless, recent studies in mice have
suggested that aberrant functioning of the endocannabinoid
system in the oviduct leads to embryo retention and may be a
cause of tubal pregnancy in women [4,5].
Exposure to marijuana and its cannabinoid derivatives is
reported to have many adverse effects on reproductive functions,
including reduced fertilizing capacity of sperm, retarded develop-
ment of the embryo, fetal loss and pregnancy failure [6–11]. Both
the exogenous and endogenous cannabinoids (endocannabinoids)
act through their G protein-coupled cannabinoid receptors (CB1
and CB2) but the exact mechanism by which their wide-ranging
effects are mediated has yet to be defined [11,12].
Nonetheless, in the mouse oviduct, it has been shown that a finely
regulatedendocannabinoid tone mediatedbyCB1regulatesnormal
oviductal transport of embryos [11]. Transport of the embryo is
aided by a wave of oviduct smooth muscle movement controlled by
the sympathetic nervous system [13]. Stimulation of b2-adrenergic
receptors (b2-AR) causes smooth muscle relaxation and stimulation
of a1-adrenergic receptors (a1-AR) causes smooth muscle contrac-
tion, leading to a wave of relaxation and contraction [13,14].
Exposure of oviducts to either an a1-AR agonist, or a b2-AR
antagonist, causes embryos to be retained in the oviduct. CB1
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nerve terminals in CB12/2 mice have increased release of
norepinephrine (NE) [4]. Moreover, studies have shown that
CB12/+ embryos have normal pre-implantation development in
CB12/2 oviducts but about 40% of the CB12/2 mothers still
showpregnancylossduetooviductalembryoretention[4,15].Allof
these observations have led to the proposal that CB1-mediated
endocannabinoid signaling is functionally coupled to adrenergic
signalingandthe oviductalmuscleisthoughttobepredominantlyin
a contraction (retention) phase in the absence of CB1. Although
there is no evidence for implantation of embryos in the mouse
oviduct, embryos can implant in the human Fallopian tube, and this
could be a potential underlying mechanism for ectopic pregnancy.
Both adrenergic receptors have been identified in the human
Fallopian tube and there is evidence of similar adrenergic control
of human oviductal smooth muscle activity [16–18]. However,
CB1 expression has not been demonstrated to our knowledge in
the human Fallopian tube or endometrium. Furthermore, the
suggestive differences we see in polymorphic alleles of the CNR1
gene encoding for CB1 (see Figure 1) between cohorts of women
with ectopic versus intra-uterine pregnancies needs further study
to determine if they could contribute to the incidence of ectopic
pregnancy [19,20].
The aims of this study were therefore to demonstrate CB1
expression in the human Fallopian tube and endometrium from
non-pregnant women and women with ectopic and intra-uterine
pregnancies, and determine the distribution of CNR1 polymor-
phisms in women with ectopic and intra-uterine pregnancies.
Methods
Tissue collection
Ethical approval for this study was obtained from Lothian
Research Ethics Committee (04/S1103/20). All women were aged
18–45 years (mean 38). Written and informed consent was obtained
from all patients before sample collection. Fallopian tube biopsies,
endometrial biopsies (for histological dating) and sera (for
measurement of circulating estradiol and progesterone concentra-
tions for endocrine staging) were collected from women undergoing
gynecological procedures for benign conditions (see Table 1) and
women undergoing surgical management of tubal ectopic pregnan-
cy. Endometrial biopsies and whole blood samples were obtained
from women with viable pregnancies undergoing surgical termina-
tion of first trimester pregnancy (STOP, group 1, n=8, mean
gestation=58.7d), from women with non-viable pregnancies
undergoing surgical management of embryonic missed miscarriage
in the first trimester (n=6, group 2, mean gestation=57.7d) and
women undergoing surgical management of tubal ectopic pregnan-
cy (n=11, group 3, mean gestation=58.1d). None of the women
undergoing surgical management of ectopic pregnancy presented
acutely with haemodynamic shock, and all required serial serum
beta-HCG and ultrasound monitoring prior to diagnosis. Endome-
trium and trophoblast were obtained by suction curettage from
groups 1 and 2. Endometrium was obtained by Pipelle
TM
endometrial biopsy from group 3. The decidualized endometrium
was isolated from the trophoblast macroscopically in saline. Part of
the Fallopian tube and endometrial biopsies were (a) immersed in
RNAlater
TM (Ambion, Texas, USA) at 4uC overnight then flash
frozen at 270uC; (b) fixed in 10% neutral buffered formalin
overnight at 4uC, stored in 70% ethanol, and wax embedded; and
(c) immersed in Hanks/HEPES buffer then microwave irradiated
before transfer to 10% sucrose/PBS and stored at 4 C for
30 minutes. Part (c) was then immersed in OCT freezing medium
(Bayer Diagnostics) (correctly oriented in a mould), snap-frozen in
liquid nitrogen and stored at 280 C before being cut into 5 um
sections for immunohistochemistry (preparation of frozen speci-
mens adapted from Slayden et al, 1995). Decidual parietalis
(decidualized endometrium without trophoblast) was confirmed
(usingpart(b)ofallbiopsies)byhaematoxylinand eosinstainingand
immunolocalisation of cytokeratin prior to RT-PCR. A standard
immunohistochemical protocol was used [21]. Tissue sections were
incubated with mouse anti-cytokeratin primary antibody (1:60,
Dako, Ely, UK) for one hour at 37uC followed by incubation with
biotinylated horse anti-mouse (1:2000) and ABC (both Vector,
Peterborough, UK) for 30 minutes at room temperature.
Quantitative real-time PCR
Total RNA was extracted from the Fallopian tube and
endometrial biopsies as detailed in the manufacturers’ protocol
(Qiagen, West Sussex, UK). The concentration and quality of the
extracted RNA was assessed using an Agilent bioanalyser. All
samples were standardised for quality control and assigned an
RNA integrity number (RIN). RNA samples were considered to be
of good quality when a mean RIN value of 7.5 was obtained [22].
CB1 levels were determined by quantitative real-time PCR. This
technique relates the amount of CB1 mRNA present to levels of
ribosomal 18S, controlling for the amount of RNA present. Details
of the RT and PCR methods have been fully detailed elsewhere
[23]. Specific human CB1 primers and probe (pre-validated
Taqman gene expression assay) were obtained from Applied
Biosystems (Foster City, CA). Within-assay variation of PCR
measurements were calculated from six replicates. The variability
of the RT step was determined by reverse transcribing one RNA
sample on eight separate occasions. The eight complementary
DNA samples were then included within one PCR run, and
variability (relative to SD) was calculated. The possibility of
genomic DNA contamination was excluded by DNAase treatment
and by measurement of beta-actin levels in RNA samples (which
were not reverse transcribed). The relative mean of the samples
from each clinical group was logged and analysed by analysis of
variance (ANOVA) followed by Kruskal Wallis post hoc analysis.
CB1 immunohistochemistry
Frozen tissue sections were fixed for 30 minutes in cold acetone
at 220uC then allowed to air-dry for two hours. Sections were
washed in TBS+0.5% Triton-X (TBSTX) for 10 minutes before
blocking of non-specific endogenous peroxidase activity with 3%
hydrogen peroxide (Sigma Aldrich, Poole, UK) in distilled water
for 10 minutes at room temperature. Following a further wash in
Figure 1. Genomic organization of CNR1 gene and SNPs. The
CNR1 gene is a single exon gene located on chromosome 6q14–15 that
is represented by a rectangle box (the orientation of the transcription of
the gene is indicated by the arrow). The SNPs genotyped are
represented by the vertical lines and their position in base pairs
according to their chromosomal location. The names of the CNR1 SNPs
according to the NCBI database are indicated by the prefix ‘rs’.
doi:10.1371/journal.pone.0003969.g001
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was applied for 20 minutes prior to application of cannabinoid
receptor 1 antibody (rabbit polyclonal, Abcam, Cambridge, UK)
diluted 1:300 in normal goat serum. Sections were incubated
overnight at 4uC then washed in TBSTX. For the negative control
sections, the primary antibody (diluted 1:300) was pre-incubated in
antibody diluent for three hours at room temperature with fifty
times the amount of cannabinoid receptor 1 peptide (Abcam,
Cambridge, UK) prior to the overnight incubation. A biotinylated
goat anti-rabbit secondary antibody (Vector Laboratories, Burlin-
game, CA) was applied for 30 minutes at room temperature, then
washed in TBSTX before a horseradish peroxidase detection
system was applied for 30 minutes (ABC-Elite, Vector Laborato-
ries). Immunoreactivity was detected using the chromagen, 3,39-
diaminobenzidine (ImmPACT DAB, Vector) followed by coun-
terstaining of sections with Harris’s haematoxylin (Pioneer
Research Chemicals, Colchester, UK) and mounted in Pertex
(Cell-path, Hemel Hempstead, UK).
Extraction of genomic DNA from whole blood
Genomic DNA was purified from 2 ml frozen whole blood
samples using the QIAamp Blood Midi Kit (Qiagen, West Sussex,
UK) as per the manufacturers’ protocol. The DNA was quantified
using a ND-1000 spectrophotometer (Nanodrop technologies, DE,
USA).
PCR analysis of genomic DNA (see Figure 1)
The 1359G/A (rs1049353) single nucleotide polymorphism
(SNP) encoding a synonymous Thr at amino acid 453 residue and
the rs806368 C/T SNP in the 39 UTR of the of the CNR1 gene
were genotyped using the Applied Biosystems TaqMan SNP
Genotyping Assays (C_ 1652590_10 and C_8943804_10). The
recommended protocols were followed using an ABI 7500 Real
Time PCR System with reaction volumes of 25 rather than 50 ml
and all reagent volumes reduced by 1/2. The genotypes were
compared using Likelihood Ratio and Pearson analyses.
Results
CB1 mRNA expression in human Fallopian tube
In the normal human Fallopian tube, CB1 mRNA was higher in
the progesterone-dominant luteal phase (mean DCT 15.426SEM
0.42, n=5) compared to the follicular phase (mean DCT
18.456SEM 0.20, n=5) (p,0.05) (see Figure 2). In Fallopian tube
from women with ectopic pregnancies (n=6), CB1 mRNA
expression was low (mean DCT 19.176SEM 0.41) (p,0.05),
mimicking that of the Fallopian tube in the follicular phase (see
Figure 2).
Table 1. Demographics for Fallopian tube and endometrial biopsies from women undergoing surgery for benign gynecological
conditions.
Sample Age Parity
Cycle
phase
Serum
estradiol
(pmol/L)
Serum
progesterone
(nmol/L) Endometrium Surgery Reason for surgery Uterine pathology
1 41 2 Follicular 1022.87 0.81 Proliferative TAH HMB Adenomyosis
2 37 2 Follicular 940.44 3.82 Proliferative TAH HMB, pelvic pain Adenomyosis
3 44 3 Follicular 829.42 4.19 Proliferative TAH HMB, pelvic pain Adenomyosis, fibroid
4 36 3 Follicular 770.63 5.16 Proliferative TAH HMB No histological abnormality
5 44 2 Follicular 116.3 2.88 Proliferative STAH HMB, dysmenorrhoea No histological abnormality
6 34 2 Mid-luteal 471 62.65 Mid-secretory LAVH HMB, dysmenorrhoea Adenomyosis, fibroid
7 40 2 Mid-luteal 242 53.1 Mid-secretory TAH HMB, dysmenorrhoea No histological abnormality
8 35 2 Mid-luteal 424 76.9 Mid-secretory TAH pelvic pain No histological abnormality
9 40 5 Mid-luteal 255 49.05 Mid-secretory TAH HMB, dysmenorrhoea No histological abnormality
10 38 3 Mid-luteal 266 37.1 Mid-secretory TAH HMB No histological abnormality
11 35 4 Menstrual 73 2.67 Menstrual TAH HMB, dysmenorrhoea Adenomyosis
12 42 2 Menstrual 55 15.05 Menstrual TAH HMB No histological abnormality
TAH=total abdominal hysterectomy.
STAH=sub-total hysterectomy.
LAVH=laparoscopically-assisted vaginal hysterectomy.
HMB=heavy menstrual bleeding.
doi:10.1371/journal.pone.0003969.t001
Figure 2. CB1 expression in the Fallopian tube. CB1 mRNA
expression was lower in the follicular compared to the luteal phase. In
Fallopian tube from women with ectopic pregnancy, CB1 mRNA
expression was also low (p,0.05).
doi:10.1371/journal.pone.0003969.g002
CB1 and Ectopic Pregnancy
PLoS ONE | www.plosone.org 3 December 2008 | Volume 3 | Issue 12 | e3969CB1 mRNA expression in human decidualized
endometrium
CB1 mRNA expression was also significantly lower (p,0.05) in
the decidualized endometrium of women with ectopic pregnancies
(mean DCT 20.326SEM 0.47, n=11) compared to the endome-
trium from intra-uterine pregnancies (viable/STOP, mean DCT
15.846SEM 0.22, and non-viable/miscarriage, mean DCT
16.366SEM 0.45, combined) (n=14) (see Figure 3). Thus, low
levels of CB1 mRNA were expressed in both the Fallopian tube and
decidualized endometrium of women with tubal ectopic pregnancy.
CB1 protein expression in human Fallopian tube and
decidualized endometrium
CB1 protein was located in the smooth muscle of the wall, the
smooth muscle of the endothelial vessels and luminal epithelium of
the Fallopian tube (see Figure 4). Expression was seen in the
cytoplasm of the epithelial cells but not the nuclei. There was no
evidence of tubal stromal expression. CB1 protein was expressed
in the epithelial cells but not the stroma of the endometrium from
women with ectopic pregnancies.
CNR1 polymorphism distribution
The distribution of two CNR1 SNPs (rs1049353 and rs806368)
(see Figure 1) was compared in DNA samples from small cohorts
of women with ectopic (n=11) or intra-uterine pregnancies (viable
and non-viable combined, n=14). While rs1049353 GG homo-
zygotes constituted 55 versus 29% of ectopic and intra-uterine
cohorts, respectively (see Figure 5), differences in genotype
distributions were not statistically significant (Likelihood Ratio
and Pearson analyses yielded X
2 of 3.5 and 3.8 (p=0.18 and 0.15,
respectively). The rs806368 SNP was not informative as all ectopic
and 13/14 intra-uterine subject DNAs were TT homozygotes.
Discussion
To date, study of the role of the endocannabinoids in female
reproduction has mostly been limited to mice [10,11]. Thus, to our
knowledge, this is the first demonstration of CB1 mRNA and
protein expression in human endometrium and Fallopian tube.
Herein, we show differences in CB1 mRNA in the Fallopian tube
and pregnant (decidualized) endometrium of women with ectopic
Figure 3. CB1 mRNA expression in the decidualized endome-
trium of women with ongoing pregnancies, miscarriage and
ectopic pregnancies. In decidualized endometrium from women
with ectopic pregnancy, CB1 mRNA expression was lower than in
women with intra-uterine pregnancies (p,0.05).
doi:10.1371/journal.pone.0003969.g003
Figure 4. Immunohistochemistry for CB1 protein expression in
Fallopian tube. CB1 protein was expressed in the smooth muscle of
the wall (A and B), the smooth muscle of the endothelial vessels (A and
C) and in the cytoplasm of the luminal epithelium of the Fallopian tube
(A, B and D). There was no evidence of nuclear or stromal expression.
EPI=epithelium, STR=stroma, SM=smooth muscle, BV=blood vessel.
Scale bar=50 microns.
doi:10.1371/journal.pone.0003969.g004
Figure 5. Allelic frequencies of rs1049353 (1359G/A) and
rs806368 (39UTR) single nucleotide polymorphisms (SNPs) of
the CNR1 gene in women with ectopic and intra-uterine
(surgical termination of pregnancies and miscarriage groups
combined) pregnancies. While rs1049353 GG homozygotes consti-
tuted 55 versus 29% of ectopic and intra-uterine cohorts, respectively,
differences in genotype distributions were not statistically significant
(Likelihood Ratio and Pearson analyses had p=0.18 and 0.15,
respectively). The rs806368 SNP was not informative as all ectopic
and 13/14 intra-uterine subject DNAs were TT homozygotes.
doi:10.1371/journal.pone.0003969.g005
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of the importance of endocannabinoid signaling in normal
implantation and other pregnancy events. Furthermore, we
suggest that SNP or other variations in the gene coding for
CB1, CNR1, may possibly contribute to a predisposition to ectopic
pregnancy.
Our other finding of a temporal variation of expression of CB1
in the Fallopian tube reflects that of many genes in the
endometrium suggesting a role for progesterone in the human
endocannabinoid system [24,25]. Interestingly, progesterone in
the mouse uterus has been shown to regulate the production of
fatty acid anandamide hydrolase, an enzyme that controls the
cellular uptake and degradation of one of the major endocanna-
binoid ligands, anandamide (AEA) [26]. Given the detrimental
effects of high anandamide levels on the embryo and the oviduct,
our data further supports the idea that there is an efficient system
for its tight regulation under hormonal control.
In our study, we also show that CB1 protein is expressed
primarily in the smooth muscle of the wall and blood vessels of the
Fallopian tube, with some expression in the cytoplasm of the
luminal epithelium. This is reassuringly consistent with murine
data [11]. In the mouse oviduct, CB1 mRNA and protein are
expressed in the smooth muscle, conveniently co-localized with the
adrenergic receptors, and it is proposed that AEA levels, mediated
by CB1, regulate the release of NE to control oviduct muscle
action in the mouse [4]. Our data therefore support this proposed
mechanism for the control of Fallopian tube smooth muscle
contractility and embryo transport in humans.
CB1 mRNA was expressed in low levels in both the Fallopian
tube and pregnant endometrium of women with ectopic
pregnancies. The most obvious difference in the endometrium of
the women with ectopic compared to intra-uterine pregnancies is
the absence of trophoblast. There are no published data to our
knowledge to suggest that CB1 expression in the uterus is
regulated by local trophoblast signals. Nevertheless, the coordi-
nated down-regulation of embryonic CB1 and uterine AEA levels
are important for both embryo activation and uterine receptivity
(two events critical for successful implantation) so it is not
inconceivable that uterine CB1 expression could be under
embryonic control [15,27]. This provides an interesting potential
mechanism for the changes observed in our study. Alternatively, if
the uterine environment truly reflects that of the Fallopian tube,
the reduced expression of CB1 in the endometrium of women with
ectopic pregnancy may simply be a consequence of extra-uterine
implantation. However, it is also possible that the reduced
expression of CB1 may predispose to, rather than be a
consequence of, tubal pregnancy. This is supported by evidence
from the studies in CB1 knockout mice but it will be difficult to
design further studies to investigate this finding in humans [4].
However, our observation of suggestive differences in distribu-
tion of SNP alleles of the CNR1 gene encoding CB1 warrants
further investigation that also excludes the possibility that some
subjects with ectopic pregnancy and reduced mRNA expression
genotyped as 1359G/G homozygotes may actually be G/deletion
heterozygotes. To date, the 1359G/A SNP is considered as the
unique haplotype tagging SNP of the CNR1 gene but a direct role
of this SNP tagging of the CNR1 gene has still to be demonstrated
[20]. Indeed, despite its location in a coding region, its functional
role has not yet been established. Furthermore, as about twenty
SNPs have been identified in the CNR1 gene, further SNPs should
be tested [28]. Replication of these data in a larger sample is also
needed in order to reach the conclusion that the CNR1 gene, and
indeed CB1, is important for embryo transport and successful
intra-uterine implantation.
The demonstration of a potential role for CB1 in the etiology of
human ectopic pregnancy is important. Cigarette smoking is a
major risk factor for ectopic pregnancy and there is evidence of
altered oviductal transport in rats exposed to nicotine [1,29].
Chronic exposure of rats to nicotine affects brain endocannabinoid
levels in a region-specific manner [30]. This crosstalk may also
exist in the human female reproductive tract explaining the
association between cigarette smoking, Fallopian tube dysfunction
and ectopic pregnancy.
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